ibrutinib, iMAGINE, Imbruvica, Pharmacyclics LLC
Ibrutinib is approved for pediatric patients with chronic graft versus host disease, including a new oral suspension
Sept 2022: Ibrutinib (Imbruvica, Pharmacyclics LLC) was approved by the Food and Drug Administration for use in paediatric patients with chronic graft versus host disease (cGVHD) who are younger than 1 year old and have failed on..
Abatacept, Bristol Myers Squibb, graft-versus-host disease, GVHD, hematopoietic stem cell transplantation, Orencia
Abatacept is approved for prophylaxis of acute graft versus host disease
March 2022: Abatacept (Orencia, Bristol-Myers Squibb Company) has been approved by the Food and Drug Administration for the prevention of acute graft versus host disease (aGVHD) in adults and paediatric patients 2 years of age an..
cGVHD, Food and Drug Administration, Incyte Corp, Jakafi, Ruxolitinib
Ruxolitinib is approved for chronic graft-versus-host disease
October 2021: After failure of one or two lines of systemic therapy, the Food and Drug Administration approved ruxolitinib (Jakafi, Incyte Corp.) for chronic graft-versus-host disease (cGVHD) in adults and children aged 12 and up...
Belumosudil, chronic GVHD, graft-versus-host disease, Kadmon Pharmaceuticals, KD025-213, NCT03640481, Rezurock
The FDA has approved belumosudil for the treatment of chronic graft-versus-host disease
August 2021: After failure of at least two prior lines of systemic therapy, the Food and Drug Administration approved belumosudil (Rezurock, Kadmon Pharmaceuticals, LLC), a kinase inhibitor, for adult and paediatric patients 12 ye..
Beta Thalassemia, BMT, COVID-19, India, Thalassemia
Beta Thalassemia and its consideration with COVID-19
July 2021: Beta-thalassemia is an inherited condition caused by mutations in a gene involved in the production of a component of haemoglobin, the protein that transports oxygen throughout the body. These mutations either prohibit ..
BMT, Bone marrow transplant, Stem cell transplant
Bone marrow transplant in India
Bone marrow transplant in India Bone marrow stem cell transplants in India are performed by some of the leading cancer centres. To date, more than 10,000 successful bone marrow stem cell transplants have been performed in India. ..
Assela, Bone marrow transplant, Delhi, Ethiopia, India, Stem cell transplant
Bone marrow transplant in India – A patient story
This story is about bone marrow transplant in India. Mukhtar, who is from Assela in Ethiopia, suffers from deadly aplastic anemia. He travels to India for his stem cell transplant. Read the entire story here. Mukhtar Mukhtar is ..